Apollo Hospitals’ Q3 net profit jumps 35%, Board declares Rs 10 interim dividend

Apollo Hospitals Q3 earnings

• Apollo Hospitals' Q3 net profit jumped 35 percent to Rs.502 crore
• Consolidated revenue rose 17 percent to Rs.6,477 crore with broad-based growth
• Apollo declared an interim dividend of Rs.10 per share

Did our AI summary help?

Apollo Hospitals Enterprise Ltd. on Tuesday reported a 35 percent jump in net profit for the December quarter to Rs 502 crore, driven by strong performance across its hospitals, diagnostics and omni‑channel health‑commerce businesses, even as consolidated revenue and EBITDA delivered double‑digit growth.

The company attributed the profit surge to higher patient volumes, improved payer mix, and stronger profitability across HealthCo and healthcare services. Apollo also declared an interim dividend of Rs 10 per share.

Consolidated revenue rose 17 percent year‑on‑year to Rs 6,477 crore, supported by broad‑based growth across all business segments. EBITDA expanded 27 percent to Rs 965 crore, translating into a margin improvement of 112 basis points to 14.9 percent, even after absorbing Rs 124 crore of Apollo 24/7 costs including a Rs 38 crore non‑cash ESOP charge.

On a year‑to‑date basis, revenue for the nine‑month period grew 15 percent to Rs 18,623 crore while PAT increased 34 percent to Rs 1,412 crore, underscoring sustained operating leverage across the network.

The core Healthcare Services (hospitals) segment posted a 14 percent rise in revenue to Rs 3,183 crore, with EBITDA up 18 percent at Rs 790 crore and margins steady at 24.8 percent. Overall occupancy stood at 67 percent, with strong performance across clusters—Tamil Nadu (14 percent revenue growth), AP/Telangana (16 percent), Karnataka (16 percent), Eastern region (15 percent), Western region (17 percent), and Northern region (12 percent).

Apollo Health & Lifestyle Ltd (AHLL) recorded a 20 percent revenue increase to Rs 467 crore, led by a strong diagnostics business, and delivered 39 percent EBITDA growth. Losses narrowed, with PAT improving to –Rs 6 crore from –Rs 8 crore a year earlier.

Meanwhile, the fast‑growing Apollo HealthCo vertical—comprising digital health and the omni‑channel pharmacy distribution business—posted 20 percent revenue growth to Rs 2,827 crore and a sharp jump in EBITDA to Rs 128 crore, more than doubling from Rs 57 crore in the previous year. PAT for the vertical rose to Rs 87 crore from Rs 32 crore, supported by the addition of 185 new stores during the quarter, taking the total to 7,113 outlets. Private‑label penetration reached 15.5 percent and online transactions grew 31% year‑to‑date, strengthening the omni‑channel funnel.

Chairman Dr. Prathap C. Reddy said the quarter reflects Apollo’s “fundamental strength and clinical depth,” highlighting gains across robotics‑assisted surgery, neurosciences, oncology early‑detection programs, and transplant leadership. The company also opened a new 250‑bed quaternary hospital in Pune, the first phase of a 400‑bed development, reinforcing its ongoing capacity expansion strategy.